Daniel Bradbury - 04 Jan 2022 Form 4/A - Amendment Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Role
Director
Signature
/s/ Greg Acosta, Attorney-in-fact
Issuer symbol
CSTL
Transactions as of
04 Jan 2022
Net transactions value
-$699,104
Form type
4/A - Amendment
Filing time
13 Jun 2022, 19:00:10 UTC
Date Of Original Report
06 Jan 2022
Previous filing
10 Nov 2021
Next filing
20 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSTL Common Stock Sale $320,762 -7,303 -3% $43.92 238,690 04 Jan 2022 By LLC F1, F2, F3
transaction CSTL Common Stock Sale $188,217 -4,375 -3.2% $43.02 130,905 04 Jan 2022 By Daniel Bradbury Irrecovable Descendant's Trust F1, F4, F5
transaction CSTL Common Stock Sale $190,124 -4,375 -3.2% $43.46 130,930 04 Jan 2022 By Annette Bradbury Irrecovable Descendant's Trust F1, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted collectively by BioBrit, LLC (the "LLC"), The Annette E. Bradbury Irrevocable Descendants' Trust, and The Daniel M. Bradbury Irrevocable Descendants' Trust on November 30, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $43.750 to $44.305, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
F4 This transaction was executed in multiple trades at prices ranging from $42.695 to $43.300, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F6 This transaction was executed in multiple trades at prices ranging from $43.300 to $43.750, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.

Remarks:

This amendment is being filed to correct certain clerical errors in lines 1, 3 and 4 of Table I included in the Form 4 originally filed by the Reporting Person on January 6, 2022. This amendment corrects the allocation of shares sold on January 4, 2022, the weighted average sale prices and the range of sale prices for each transaction.